Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease

Abstract

Loss of ANXA1 expression may support inflammation during IBD and can serve as a biomarker of disease progression. Changes in ANXA1 levels may be predictive of therapeutic efficacy.